RBC Capital Starts Forward Pharma (FWP) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
JMP Securities Starts Forward Pharma (FWP) at Market Outperform
November 10, 2014 8:06 AM ESTJMP Securities initiated coverage on Forward Pharma (NASDAQ: FWP) with a Market Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Forward Pharma click here. For more ratings news on Forward Pharma click here.
Shares of Forward Pharma closed at $21.05 yesterday.
... More


